Skip to main content

Mengis Capital Management, Inc.

Position in NVS — Novartis AG

CIK 1609674 PORTLAND, OR

Position in NVS

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$10,791,482
+$1,037,456 QoQ
Shares Held
70,648
-0.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
2.19%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Mengis Capital Management, Inc. holds $32,051,953 across 6 Drug Manufacturers - General names.

# Ticker Company Shares Value (USD) Open

All Filings in NVS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $10,791,482 70,648
2025-12-31 $9,754,026 70,748
2025-09-30 $8,207,103 63,998
2025-06-30 $7,803,087 64,483
2025-03-31 $8,930,997 80,113
2024-12-31 $7,795,796 80,113
2024-09-30 $9,145,585 79,513
2024-06-30 $8,687,668 81,605
2024-03-31 $8,105,296 83,793
2023-12-31 $8,273,784 81,943
2023-09-30 $8,316,155 81,643
2023-06-30 $8,243,640 81,693
2023-03-31 $7,531,856 81,868
2022-12-31 $7,462,445 82,258
2022-09-30 $6,288,155 82,728
2022-06-30 $7,257,830 85,861
2022-03-31 $7,546,149 85,996
2021-12-31 $7,437,486 85,029
2021-09-30 $6,761,488 82,679
2021-06-30 $7,520,821 82,429
2021-03-31 $6,901,826 80,742
2020-12-31 $6,928,234 73,369
2020-09-30 $6,376,342 73,325
2020-06-30 $6,296,515 72,092
2020-03-31 $5,942,171 72,070